Guanfacine
- TRADE NAMES: Entulic; Estulic; Tenex (ESP)
- INDICATIONS: Hypertension; attention deficit hyperactivity disorder (ADHD)
- CLASS: Adrenergic alpha-receptor agonist, Anti-attention deficit hyperactivity disorder (anti-ADHD)
- HALF-LIFE: 10–30 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Conivaptan, Darunavir, Delavirdine, Efavirenz, Indinavir, Oxcarbazepine, Rifapentine, Telithromycin, Voriconazole
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 12/06/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric